GSK Sends Three London Executives To Deal With China Bribery Crisis
This article was originally published in PharmAsia News
Executive Summary
GlaxoSmithKline has dispatched three of its London-based executives, including its president of emerging markets and Asia Pacific, to China to deal with the government's investigation of company bribery allegations.